Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
Yang Yang, Md Sahidul Islam, Jin Wang, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 10, pp. 1708-1717
Open Access | Times Cited: 923

Showing 1-25 of 923 citing articles:

The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis
Charis M. Galanakis
Foods (2020) Vol. 9, Iss. 4, pp. 523-523
Open Access | Times Cited: 869
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 720
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Janice S. Mani, Joel B. Johnson, Jason C. Steel, et al.
Virus Research (2020) Vol. 284, pp. 197989-197989
Open Access | Times Cited: 430
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Amin Gasmi, Sàdaf Noor, Torsak Tippairote, et al.
Clinical Immunology (2020) Vol. 215, pp. 108409-108409
Open Access | Times Cited: 304
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan, Bilal Ahamad Paray, Arif Hussain, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 8, pp. 3025-3033
Open Access | Times Cited: 290
COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
Kajal Rawat, Puja Kumari, Lekha Saha
European Journal of Pharmacology (2020) Vol. 892, pp. 173751-173751
Open Access | Times Cited: 281
Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective
Suraphan Panyod, Chi‐Tang Ho, Lee‐Yan Sheen
Journal of Traditional and Complementary Medicine (2020) Vol. 10, Iss. 4, pp. 420-427
Open Access | Times Cited: 276
The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review
Hengfeng Liao, Jun Ye, Lili Gao, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110917-110917
Open Access | Times Cited: 216
Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review
Charis M. Galanakis, Turki M.S. Aldawoud, Myrto Rizou, et al.
Foods (2020) Vol. 9, Iss. 11, pp. 1701-1701
Open Access | Times Cited: 215
In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Seshu Vardhan, Suban K. Sahoo
Computers in Biology and Medicine (2020) Vol. 124, pp. 103936-103936
Open Access | Times Cited: 210
Natural products' role against COVID-19
Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio da Veiga
RSC Advances (2020) Vol. 10, Iss. 39, pp. 23379-23393
Open Access | Times Cited: 209
Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Lin Ang, Eunhye Song, Hye Won Lee, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1583-1583
Open Access | Times Cited: 208
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Quyuan Tao, Jiaxin Du, Xiantao Li, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 8, pp. 1345-1353
Open Access | Times Cited: 192
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research
Sayeed Ahmad, Sultan Zahiruddin, Bushra Parveen, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 183
Medicinal Plants as Sources of Active Molecules Against COVID-19
Bachir Benarba, Atanasio Pandiella
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 180
The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention
Hayat Ouassou, Loubna Kharchoufa, Mohamed Bouhrim, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 176
Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 165
Tea and tea drinking: China’s outstanding contributions to the mankind
Si-Yuan Pan, Qu Nie, Hai‐Chuan Tai, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 165
Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
David Y.W. Lee, Qing Y. Li, Jing Liu, et al.
Phytomedicine (2020) Vol. 80, pp. 153337-153337
Open Access | Times Cited: 164
COVID-19 Pandemic: an Overview of epidemiology, pathogenesis, Diagnostics and Potential Vaccines and Therapeutics
Haneen Amawi, Ghina’a Abu Deiab, Alaa A. A. Aljabali, et al.
Therapeutic Delivery (2020) Vol. 11, Iss. 4, pp. 245-268
Open Access | Times Cited: 158
A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)
Amir Mirzaie, Mehrdad Halaji, Farhad Safarpoor Dehkordi, et al.
Complementary Therapies in Clinical Practice (2020) Vol. 40, pp. 101214-101214
Open Access | Times Cited: 154
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
Liqiang Ni, Lili Chen, Xia Huang, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 7, pp. 1149-1162
Open Access | Times Cited: 154
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Xiaofei Chen, Yun‐Long Wu, Chun Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 222-236
Open Access | Times Cited: 153
Page 1 - Next Page

Scroll to top